Gordon, Caroline

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 5,322

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 2,011

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 762

The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus

Gladman, D. D., Urowitz, M. B., Goldsmith, C. H., Fortin, P., Ginzler, E., Gordon, C., Hanly, J. G., Isenberg, D. A., Kalunian, K., Nived, O., et al. (1997) · Arthritis & Rheumatism

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 759

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task Force of the EULAR standing Committee for clinical Affairs

Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., Cervera, R., Dalakas, M., Doria, A., Hanly, J. G., et al. (2010) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 742

Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus

McElhone, K., Abbott, J., Shelmerdine, J., Bruce, I. N., Ahmad, Y., Gordon, C., Peers, K., Isenberg, D., Ferenkeh‐Koroma, A., Griffiths, B., et al. (2007) · Arthritis Care & Research

Systemic Lupus Erythematosus ResearchHealth Education and Validation

Cited by 341

Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials

Clowse, M. E. B., Wallace, D. J., Furie, R. A., Petri, M. A., Pike, M. C., Leszczyński, P., Neuwelt, C. M., Hobbs, K., Keiserman, M., Duca, L., et al. (2017) · Arthritis & Rheumatology

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 235

Hydroxychloroquine-related retinal toxicity

Ding, H. J., Denniston, A. K., Rao, V. K., & Gordon, C. (2016) · Rheumatology

Drug-Induced Ocular ToxicityOcular and Laser Science Research

Cited by 100

Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

Choi, M. Y., Chen, I., Clarke, A. E., Fritzler, M. J., Buhler, K. A., Urowitz, M., Hanly, J., St-Pierre, Y., Gordon, C., Bae, S.-C., et al. (2023) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 89

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Mendel, A., Bernatsky, S., Askanase, A., Bae, S.-C., Clarke, A. E., Costedoat-Chalumeau, N., Gladman, D. D., Gordon, C., Hanly, J., Jacobsen, S., et al. (2021) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchCOVID-19 and healthcare impacts

Cited by 41

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality

Becker, Y. L. C., Boilard, É., Rollet-Labelle, E., Lood, C., Julien, A.-S., Abrahamowicz, M., Allaeys, I., Choi, M., Leclerc, J., Lévesque, T., et al. (2026) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 3